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What common substances can
cause false positives on urine
screens for drugs of abuse?
E V I D E N C E - B A S E D A N SW E R
C L I N I C A L C O M M E N TA R Y
False-positive reports on urine drug
screens by immunoassay are rare (strength
of recommendation [SOR]: C, small 
controlled-exposure studies, small case
series). Nonsteroidal anti-inflammatory
drugs, fluoroquinolones, and Vicks Inhaler
are most frequently implicated (TABLE).
Ruling out a false-positive result requires
confirmation with a more specific test,
usually gas chromatography/mass 
spectrometry (GC-MS). A true-positive 
drug screen may occur in a urine specimen
from a patient who legally or unknowingly
ingests a product that is metabolized to a
drug of abuse. Passive exposure to a 
substance is unlikely to cause a positive
drug screen (SOR: B, small controlled-
exposure studies).
Having a plan makes 
communication less emotional 
when the results come back
Before I order a urine drug screen I ask
myself, “What will I do with the results?”
If other substances are present, will I
discontinue controlled substances or refer
to psychiatry or pain management? I also
ask patients what they think I will find. On
several occasions, patients have admitted
to taking recreational drugs that the drug
screen misses. Having a plan makes 
communication less emotional for both 
the provider and patient when the results
come back.
You should be able to follow-up results
promptly and order a GC-MS if indicated. In
addition, if working in a group, indicate a
plan for follow-up in your progress notes so
that the patient gets a consistent message.
Mary M. Stephens, MD, MPH
East Tennessee State University, Kingsport
z Evidence summary
Two different assays are commonly avail-
able for urine drug testing. The immuno-
assay is quick, highly sensitive, and rela-
tively inexpensive but may lack specificity.
It tests for classes of drugs (such as opiates)
without distinguishing among individual
drugs within that class. Gas chromatogra-
phy in combination with mass spectro-
metry (GC-MS) is a more expensive and
time-consuming test, but is the gold stan-
dard for confirming a positive result on
immunoassay. By definition, all positive
results on GC-MS are true positives.
Reports of false-positive urine drug
screening for substances of abuse are
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Substances reported to cause false-positive urine drug screen results
infrequent and limited to case reports and
a few controlled-exposure studies. The
TABLE lists some of the substances reported
to cause false-positive results.
Positive confirmation tests may occur
in urine specimens from patients who legal-
ly or unknowingly ingest products that
contain drugs of abuse. In these instances,
the finding is a true positive but may not
reflect drug abuse by the client. Many
products available without prescription
outside of the US contain opiates (eg,
Donnagel PG from Canada).1 Several con-
trolled-exposure studies have shown that
as little as 1 poppy seed muffin (about 15 g
of seed) can produce detectable amounts of
morphine and codeine by immunoassay as
well as GC-MS.1,2 In 1998, the federal gov-
ernment increased the threshold defining a
positive screen for urine morphine and
codeine from 300 to 2000 ng/mL to reduce
spurious reports of opiate-positive tests
from poppy seed consumption.1,2
Substances that do not produce posi-
tive urine drug screens include passively
inhaled crack cocaine or marijuana (unless
“extreme”), and ingested products contain-
ing hemp or other common herbal prepara-
tions.1,2,10 In one study, 6 volunteers in an 
8 × 8 × 7-ft enclosed room were exposed to
200 mg freebase cocaine vapor; none of
their urine samples exceeded the federal
GC-MS threshold. In a similar study of 3
non-smokers exposed to 8 marijuana
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SUBSTANCE FALSELY
IDENTIFIED ON TEST ACTUAL SUBSTANCE TYPE OF STUDY NOTES
Amphetamine and Selegiline Single case report1,2 L-stereoisomer only detected
methamphetamine (D-stereoisomer present in 
illicit drugs)
Amphetamine and Vicks Inhaler Several case reports, L-stereoisomer only detected;
methamphetamine controlled-exposure most positives noted with twice
studies1–3 recommended dosage
Barbiturate NSAIDs Controlled-exposure 0.4% false-positive rate
(ibuprofen, naproxen) study of 60 subjects
(510 specimens)4
Benzodiazepine Oxaprozin Controlled-exposure 100% false-positive rate,
study of 12 patients some cases lack controls
(36 specimens)5
Cannabinoid NSAIDs Controlled-exposure 0.4% false-positive rate
(ibuprofen, naproxen) study of 60 subjects
(510 specimens)4
Opiate Fluoroquinolone* Controlled-exposure Most levels detected were 
studies (8 subjects) and below new 1998 threshold 
case series (9 subjects)6 (2000 ng/mL)
Opiate Rifampin 3 case reports7
Phencyclidine Venlafaxine 1 case report8 Confirmed by GC-MS 
(7200 mg intentionally ingested)
Phencyclidine Dextromethorphan 1 case report9 (500 mg ingested)
*Ofloxacin and levofloxacin most likely to cause false positive.
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smokers (smoking 32 joints) in a 10 × 10 ×
8-ft enclosed room, no samples from the
nonsmokers exceeded the federal GC-MS
threshold.2 In an exposure study of 90 
volunteers who ingested 8 different herbal
preparations, there were no positive urine
drug screens.1
Recommendations from others
The US Department of Health and Human
Services requires confirmation of positive
immunoassay results by GC-MS for drug
testing in the workplace.1 The College of
American Pathologists, the principal organ-
ization of board-certified pathologists,
states: “Confirmation testing, a standard of
practice in forensic toxicology, should be
performed in clinical toxicology whenever
possible.”11
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